Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.

[1]  David I. Lee,et al.  A multinational, multi-institutional study comparing positive surgical margin rates among 22393 open, laparoscopic, and robot-assisted radical prostatectomy patients. , 2014, European urology.

[2]  M. Menon,et al.  Use of advanced treatment technologies among men at low risk of dying from prostate cancer , 2014, BJU international.

[3]  Steven L. Chang,et al.  Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Steven L. Chang,et al.  MP51-19 COMPARATIVE EFFECTIVENESS OF ROBOTIC-ASSISTED AND OPEN RADICAL PROSTATECTOMY IN THE “POST-LEARNING CURVE” ERA , 2014 .

[5]  W. Lowrance,et al.  Costs of radical prostatectomy for prostate cancer: a systematic review. , 2014, European urology.

[6]  D. Hershman,et al.  Robotic vs laparoscopic hysterectomy--reply. , 2013, Journal of the American Medical Association (JAMA).

[7]  M. Wirth,et al.  Re: Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, et al. systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62:405-17. , 2013, European urology.

[8]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[9]  B. Trock,et al.  Impact of surgical margin status on prostate‐cancer‐specific mortality , 2012, BJU international.

[10]  L. Egevad,et al.  Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years. , 2012, European urology.

[11]  H. G. van der Poel,et al.  Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. , 2012, European urology.

[12]  J. Nelson,et al.  Comparative hospital cost-analysis of open and robotic-assisted radical prostatectomy. , 2012, Urology.

[13]  R. Karnes,et al.  Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series. , 2012, European urology.

[14]  B. Spencer.  Utilization and expense of adjuvant cancer therapies following radical prostatectomy , 2011, Cancer.

[15]  F. Montorsi,et al.  Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors , 2011, Cancer.

[16]  B. Skipper,et al.  SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: results of a systematic audit. , 2011, The Journal of urology.

[17]  S. Lipsitz,et al.  Population‐based determinants of radical prostatectomy surgical margin positivity , 2011, BJU international.

[18]  Ronald C. Chen,et al.  Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. , 2011, The Journal of urology.

[19]  G. Barbash,et al.  New technology and health care costs--the case of robot-assisted surgery. , 2010, The New England journal of medicine.

[20]  Usha Kreaden,et al.  Visual cues as a surrogate for tactile feedback during robotic‐assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive patients , 2010, BJU international.

[21]  W. Ellis,et al.  Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. , 2010, The Journal of urology.

[22]  P. Carroll,et al.  Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. , 2010, Urologic oncology.

[23]  S. Boorjian,et al.  The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. , 2010, The Journal of urology.

[24]  S. Lipsitz,et al.  Comparative effectiveness of minimally invasive vs open radical prostatectomy. , 2009, JAMA.

[25]  E. Messing,et al.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.

[26]  J. Moul,et al.  Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. , 2008, European urology.

[27]  Wadih Arap,et al.  Quality of life and satisfaction with outcome among prostate-cancer survivors. , 2008, The New England journal of medicine.

[28]  W. Lowrance,et al.  Contemporary open radical cystectomy: analysis of perioperative outcomes. , 2008, The Journal of urology.

[29]  M. Kattan,et al.  Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. , 2005, The Journal of urology.

[30]  I. Thompson,et al.  Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  K. Armstrong,et al.  Survival associated with treatment vs observation of localized prostate cancer in elderly men. , 2006, JAMA.

[32]  E. Messing,et al.  Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. , 2006, JAMA.

[33]  N. Keating,et al.  Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  D. Theodorescu,et al.  Cancer incidence after localized therapy for prostate cancer , 2006, Cancer.

[35]  M. Zelefsky.  Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) , 2006 .

[36]  M. Soloway,et al.  Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. , 2006, The Journal of urology.

[37]  M. Piérart,et al.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.

[38]  Victor Reuter,et al.  Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. , 2003, The Journal of urology.

[39]  S. Mehta,et al.  Temporal trends in radical prostatectomy complications from 1991 to 1998. , 2003, The Journal of urology.

[40]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[41]  M. Soloway,et al.  Intraoperative T staging in radical retropubic prostatectomy: is it reliable? , 2001, Urology.

[42]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[43]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .

[44]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .